Company Transitioned onto the OTC Pink CRANBURY, N.J., May 8, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTC PINK: PTNT) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin...
Read More Details
Finally We wish PressBee provided you with enough information of ( Palatin Technologies Announces Closing of Reduced Public Offering )
Also on site :